| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
| mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.099 |
0.05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |